The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kekelidze Z.I.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia

Klimenko T.V.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia;
Russian State University of Justice, Moscow, Russia

Kozlov A.A.

Kafedra i klinika fakul'tetskoĭ khirurgii, kafedra obshcheĭ i klinicheskoĭ patologii Samarskogo gosudarstvennogo meditsinskogo universiteta, Samarskaia GKB #1 im. N.I. Pirogova

Shakhova S.M.

Moscow Research and Practical Centre for Narcology of the Department of Public Health of Moscow, Moscow, Russia;
Sechenov First Moscow State Medical University, Moscow, Russia

Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids

Authors:

Kekelidze Z.I., Klimenko T.V., Kozlov A.A., Shakhova S.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(12): 21‑26

DOI: 10.17116/jnevro201711712121-26

Read: 1309 times

Download PDF (RU)
Contact the author
Table of contents

DIFFERENTIAL APPROACHES TO THE TREATMENT OF ACUTE PSYCHOSIS DUE TO THE USE OF SYNTHETIC CANNABINOIDS
DIFFERENTIAL APPROACHES TO THE TREATMENT OF ACUTE PSYCHOSIS DUE TO THE USE OF SYNTHETIC CANNABINOIDS

To cite this article:

Kekelidze ZI, Klimenko TV, Kozlov AA, Shakhova SM. Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(12):21‑26. (In Russ.)
https://doi.org/10.17116/jnevro201711712121-26

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Comparative study of cognitive impairment in subgroups of bipo­lar affe­ctive diso­rder types I and II, occu­rring with and without psychotic symptoms. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):7-11
The role of the rs1800795 poly­morphism of the inte­rleukin 6 gene in the deve­lopment of cognitive defi­cits asso­ciated with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):113-120
Abstract:

Based on the study of 43 patients with acute psychosis due to the use of synthetic cannabinoids, the authors showed that the inclusion of neuroleptic drugs in the complex therapy increases the efficacy of therapy. In choosing a neuroleptic it is important to take into account not only the psychopathological structure of psychosis, but also the severity of somatic and neurological disorders associated with psychosis.

Keywords:

new psychoactive substances
synthetic cannabinoids
spice
psychosis

Authors:

Kekelidze Z.I.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia

Klimenko T.V.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia;
Russian State University of Justice, Moscow, Russia

Kozlov A.A.

Kafedra i klinika fakul'tetskoĭ khirurgii, kafedra obshcheĭ i klinicheskoĭ patologii Samarskogo gosudarstvennogo meditsinskogo universiteta, Samarskaia GKB #1 im. N.I. Pirogova

Shakhova S.M.

Moscow Research and Practical Centre for Narcology of the Department of Public Health of Moscow, Moscow, Russia;
Sechenov First Moscow State Medical University, Moscow, Russia

Close metadata

References:

  1. Vsemirnyi doklad o narkotikakh. 2016. Accessed May 10, 2017. (In Russ.) http://www.unodc.org/doc/wdr2016/WDR_2016_ExSum_russian.pdf
  2. National Institute on Drug Abuse. DrugFacts: K2/Spice («Synthetic Marijuana»). Accessed May 10, 2017. (In Russ.) https://www.drugabuse.gov/drugs-abuse/synthetic-cannabinoids-k2spice
  3. European Monitoring Centre for Drugs and Drug Addiction. Synthetic cannabinoids and «Spice» profile. Accessed May 10, 2017. (In Russ.) http://www.emcdda.europa.eu/publications/drug-profiles/synthetic-cannabinoids
  4. Bokhan NA, Selivanov GYu. Klinicheskaya tipologiya psikhopatologicheskikh rasstroistv u potrebitelei sinteticheskikh kannabinoidov (spaisov). Sibirskii vestnik psikhiatrii i narkologii. 2015;4(89):18-23. (In Russ.)
  5. Fattore L. Synthetic Cannabinoids — Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Biological Psychiatry. 2016;79:539-548.
  6. Bondar’ IV, Nadezhdin AV, Vyazovichenko YuE, Simonov DV, Vishnyakov DA. Ob aktual’nosti problemy kuritel’nykh smesei (spaisov) na sovremennom etape. Sbornik materialov Vserossiiskoi nauchno-prakticheskoi konferentsii «Protivodeistvie nezakonnomu oborotu narkoticheskikh sredstv, psikhotropnykh veshchestv, ikh analogov i prekursorov v sovremennoi rossii: ugolovno-pravovoi i kriminologicheskii aspekty». Pod obshch. red. Batyrshina I.I. M.: FKU NITs FSKN Rossii; 2015;27-32. (In Russ.)
  7. Savchuk SA. Obnaruzhenie sinteticheskikh kannabimimetikov, narkoticheskikh, psikhoaktivnykh veshchestv i ikh metabolitov v moche, volosakh i nogtyakh metodami zhidkostnoi khromatografii s mass-spektrometricheskim detektirovaniem. Informatsionnoe pis’mo. Narkologiya. 2014;8:42-52. (In Russ.)
  8. Klimenko ТV, Shakhova SМ, Kozlov AA. Psychotic disorders after use of synthetic cannabinoids (spice). Siberian herald of Psychiatry and Addiction Psychiatry. 2017;2(95):25-29. (In Russ.)
  9. Bazire S. Risperidone in schizophrenia. The British Journal of Psychiatry. 1996;168(1):128. https://doi.org/10.1192/bjp.168.1.128a
  10. Belousov YuB, Moiseev VS, Lepakhin VK. Klinicheskaya farmakologiya i farmakoterapiya. Rukovodstvo dlya vrachei. 2-e izd. ispr. i dop. M.: Universum publishing; 1997. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.